Vagus-nerve stimulation for the treatment of epilepsy (Q35172370)

6 August 2017

1 reference

title

Vagus-nerve stimulation for the treatment of epilepsy (English)

1 reference

6 August 2017

1

Elinor Ben-Menachem

1 reference

6 August 2017

1 December 2002

1 reference

6 August 2017

1 reference

6 August 2017

1

1 reference

6 August 2017

8

1 reference

6 August 2017

477-482

1 reference

J.L. Corning and vagal nerve stimulation for seizures in the 1880s

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Inhibition of experimental seizures in canines by repetitive vagal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

The effect of vagal afferent stimulation on the EEG pattern of the cat

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Cortical and subcortical patterns of response to afferent vagal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Afferent vagal stimulation: Neurographic correlates of induced eeg synchronization and desynchronization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

EEG changes with vagus nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Effects of vagal stimulation on experimentally induced seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Feasibility and safety of vagal stimulation in monkey model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Efficacy and safety of vagus nerve stimulation in patients with complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Treatment of epilepsy by stimulation of the vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation activates central nervous system structures in epileptic patients during PET H2(15)O blood flow imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Cardiorespiratory variables and sensation during stimulation of the left vagus in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Airway effects of direct left-sided cervical vagal stimulation in patients with complex partial seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Clinical experience with a helical bipolar stimulating lead

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Long-term continuation of levetiracetam in patients with refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagal nerve stimulation in tuberous sclerosis complex patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagal nerve stimulation for status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Left vagal nerve stimulation in six patients with hypothalamic hamartomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation in 16 children with refractory epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Enhanced recognition memory following vagus nerve stimulation in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Exploration of Changes in Health-Related Quality of Life after 3 Months of Vagus Nerve Stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Ventricular asystole during vagus nerve stimulation for epilepsy in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Aspiration: a potential complication to vagus nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Vagus nerve stimulation treatment for Lennox-Gastaut syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Chronic stimulation of the left vagal nerve in children: effect on swallowing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Assessment of vagus nerve stimulation for epilepsy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900220-X

7 January 2021

10.1016/S1474-4422(02)00220-X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12849332